Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
Published in Medical Letter on the CDC and FDA, March 21st, 2010
Total revenues for the quarter ended December 31, 2009 were $38.3 million, compared to $19.6 million for the quarter ended December 31, 2008. Total revenues for the year ended December 31, 2009 were $128.4 million, compared to $67.5 million for the year ended December 31, 2008. Contract revenues for 2009 of $11.1 million included the recognition of a $10.0 million milestone payment from UCB Pharma Limited received in 2008.
XYREM® (sodium oxybate) oral solution net sales increased 100% to $31.6 million for the quarter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- JAMA and Archives Journals
Study examines outcomes associated with anemia management for patients with end-stage renal disease - Johns Hopkins University Bloomberg School of Public Health
Mosquitoes -- not birds -- may have carried West Nile virus across US - Wiley-Blackwell
Small wings travel far to spread West Nile virus - Chronic Obstructive Pulmonary Disease
Research from University of Connecticut in chronic obstructive pulmonary disease provides new insights - Fluorescein Therapy
Research on fluorescein therapy reported by M.B. Wallace et al - HIV/AIDS
Research from P.S. Belperio and co-authors provides new data about HIV/AIDS - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
